Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-27 Sale | 2024-02-29 7:53 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 118,922 | $55 | $6,540,710 | 2,967,554 (Indirect Direct) | View |
| 2024-02-20 Sale | 2024-02-22 6:32 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 21,078 | $57.33 | $1,208,418 | 3,086,476 (Indirect Direct) | View |
| 2024-02-14 Sale | 2024-02-16 6:02 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 60,000 | $60.91 | $3,654,800 | 3,107,554 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-01 Conversion | 2023-10-03 7:27 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 2,645,842 | $0 | 202,152 (Indirect) | View |
| 2023-10-01 Disposition | 2023-10-03 7:27 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 2,569,458 | $0 | 202,152 (Indirect) | View |
| 2023-04-05 Conversion | 2023-04-07 4:05 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 615,876 | $0 | 2,847,994 (Indirect) | View |
| 2023-04-05 Disposition | 2023-04-07 4:05 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 598,096 | $0 | 2,847,994 (Indirect) | View |
Ownership | 2022-04-15 4:07 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 0 | $0 | 3,463,870 (Indirect) | View |